Attorneys for Combe tell HBW Insight that the USPTO appeal board’s decision recognizes the marketplace power of a popular brand like Vagisil. Marke Enterprises' proposed Vagisert trademark for similar product was rejected. 

Former FDA Commissioner Stephen Hahn and former CDC Director Robert Redfield said leaders of their agencies and NIH  should be selected outside the election schedule. White House task force reviewing political interference with agency science.

FDA is conducting lab testing on CBD products with funding in its FY2021 appropriations, says senior agency advisor Sharon Mayl. Some work planned work in the area has been delayed by the agency's response to COVID-19.

Former FDA commissioner says legislative carve-out for a regulatory pathway for cannabinoids is a better option than a rulemaking, which could take five years and “may not even work.” Cannabinoids market is “well far ahead of where the regulation is,” he says.

Advocates hoped a study suggesting octocrylene in sunscreens may degrade into benzophenone would convince lawmakers to expand ban, but a House committee maintained its commitment to wait on more research.

FDA also approves packaging redesign for Mucinex and Mucinex-DM and final changes to labeling text and location on packaging. Granules Pharmaceuticals’ generic of Excedrin Migraine also among CDER’s decisions on OTC ANDAs and sNDAs during January-March.

The latest European consumer health business news: France's Mayoly Spindler acquires Italian supplements specialist Biohealth; UK-based Flarin gets funding to expand at home and abroad; and Sweden's Karo plots further M&A in 2021.

A round-up of the latest consumer health industry news: Takeda completes the sale of its Japanese OTC business, which has rebranded as Alinamin; Reckitt drops the "Benckiser" from its name to signal new approach; Enzymatica looks to raise funds as COVID continues to bite; and Royal DSM expands its portfolio through a new deal with Amyris. 

Latest European consumer health business news: BioGaia sets up an investment arm to identify interesting start-ups, France's Boiron expands its Spain offering with Iprad deal, and GSK ends talks with Hikma over the sale of its Egyptian OTC business.

Attorneys for Combe tell HBW Insight that the USPTO appeal board’s decision recognizes the marketplace power of a popular brand like Vagisil. Marke Enterprises' proposed Vagisert trademark for similar product was rejected. 

Wellness products accounted for the highest number of launches among health, wellness and beauty products at independent pharmacies in 2020. But the overall number slumped 21.1% due to the pandemic, according to Hamacher Resource Group’s report on a product rating system.

UK men's health platform Numan continues its mission of disrupting the consumer health industry with its acquisition of Sweden’s Vi-Health technology – a Class I medical device that includes an artificial intelligence-powered symptom checker, as well as advanced e-consultation and workflow automation tools.

In addition to distributing to Target stores, TV, radio and digital advertising and late-2020 start of sales at Kroger stores are driving Primatene Mist sales growth. The epinephrine aerosol inhaler's sales increased 186% in 2020 to $51.7m and 47% in Q4 to $13.4m.

Stada has entered the US dietary supplements category following significant gains for its Branded Products business in 2020. Acquisitions helped to drive up Branded Products sales by 27% last year, enabling Stada to become a top-five player in Europe's consumer health market. 

The latest European consumer health news: Germany's Bionorica posts double-digit sales decline due to COVID; Precision Healthcare takes Kwai to Austria; and Alfasigma hires Janssen exec to lead expanded Italy business.

Attorneys for Combe tell HBW Insight that the USPTO appeal board’s decision recognizes the marketplace power of a popular brand like Vagisil. Marke Enterprises' proposed Vagisert trademark for similar product was rejected. 

“In recent years, health and beauty products containing activated charcoal have become a consumer sensation,” and P&G/Crest has sought to capitalize on demand with falsely advertised charcoal toothpaste offerings, according to plaintiff Belinda Housey’s class action complaint in New York’s Southern District.

President Biden nominates Lina Khan for one of two FTC commissioner seats he will fill. Khan currently is a Columbia Law associate professor, teaching and writing about antitrust law, infrastructure industries law and the antimonopoly tradition.

Wellness products accounted for the highest number of launches among health, wellness and beauty products at independent pharmacies in 2020. But the overall number slumped 21.1% due to the pandemic, according to Hamacher Resource Group’s report on a product rating system.

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Mommy’s Bliss will be introducing 16 new products in 2021 for baby and kids with a focus on sleep, immunity support, digestive health, and occasional cough remedies. More product innovation news across the health, beauty and wellness sectors.

Thornton & Ross replaces the usual sponsorship design for a local soccer team's training kit with the message 'Diversity, Inclusion, Respect' during an English Football League Championship match between Huddersfield Town and Stoke City. 

Colgate Renewal toothpaste reverses early gum damage and is available in whiten, fortify enamel and sensitivity varieties. CO. by Colgate seven-product line incorporates lessons from skin care to offer “oral beauty."

The OTC Marketing Awards 2021 will now take place on 1 December, with entries invited from activity in 2020 and 2021. A special award – Best COVID-19 initiative by an OTC Company – will also recognize the efforts made by the British consumer healthcare industry during the COVID-19 pandemic.

Direct Selling Self-Regulatory Council say after UWell Life didn’t respond to its requests to substantiate ad claims made online for Primocyn brand topicals, the council submitted to its concerns to the FTC.

The National Advertising Division agreed with challenger P&G that Colgate’s evidence for Optic White Renewal Toothpaste was problematic, making its yellow stains claim potentially misleading as to the results consumers can reasonably expect.

Hisamitsu America’s severity of pain claims for Salonpas challenged by GSK are more nuanced than what label indications support, but touting its regulatory approval doesn’t convey a message that other products aren’t subject to as rigorous pre-market evaluations.